Maria Sibilia und Medical University - Info zur Person

(1 - 10 von 12

)

Dendritic cells affect onset and progress of psoriasis | EurekAlert ...www.eurekalert.org › pub_releases › e-dca

www.eurekalert.org

· ... drugs," says EMBO Member Maria Sibilia, a Professor at the Medical University of Vienna in Austria, and one of the lead authors of the study.

Study identifies tumour-promoting role of EGFR present in liver ...interventionalnews.com › News

interventionalnews.com

· A study group at the Comprehensive Cancer Centre of Medical University of Vienna and AKH Vienna under the guidance of Maria Sibilia from ...

Maria Sibilia - Find people in the EMBO Communitiespeople.embo.org › profile › maria-sibilia

people.embo.org

EMBO Member. Maria Sibilia. Medical University, Vienna | Austria. EMBO | YipC 13–16. Signaling in cancer development, innate immune cells. We employ ...

11th Tuscany Retreat on Cancer Research and Apoptosis: Genetic ...www.nature.com › cell death & disease › meeting reports › article

www.nature.com

Dec 5, · For the 11th time, an international assembly of scientists gathered in the medieval castle ... Sebastian Carotta (Boehringer Ingelheim, Vienna) presented the ... Maria Sibilia (Medical University of Vienna, Austria) indicated that ...

11th Tuscany Retreat on Cancer Research and Apoptosis: Genetic...

www.nature.com

Maria Sibilia (Medical University of Vienna, Austria) indicated that targeting EGFR on non-cancerous cells in the tumor microenvironment ...

TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate...

www.nature.com

Maria Sibilia. Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Austria. Dietmar Pils.

‪Maria Sibilia‬ - ‪Google Scholar‬

scholar.google.com

‪Institute of Cancer Research, Medical University of Vienna‬ - ‪‪อ้างอิงโดย 13,838 รายการ‬‬ - ‪tumor biology‬ - ‪inflammation‬ - ‪immunmodulation‬ - ‪cell...